Journal of Clinical Oncology , 0732-183X
Journal
Publications
- 2020
- E-pub ahead of print
Augmented reduced-intensity regimen does not improve postallogeneic transplant outcomes in acute myeloid leukemia
Charles Craddock, Aimee Jackson, Justin Loke, Ram Malladi, Keith Wheatley & 7 others, , 29 Dec 2020, In: Journal of Clinical Oncology . 12 p., JCO2002308.Research output: Contribution to journal › Article › peer-review
- E-pub ahead of print
Defining the Optimal Total Number of Chemotherapy Courses in Younger Patients With Acute Myeloid Leukemia: A Comparison of Three Versus Four Courses
Sylvie Freeman, 23 Dec 2020, In: Journal of Clinical Oncology . p. JCO2001170Research output: Contribution to journal › Article › peer-review
- E-pub ahead of print
Elective cancer surgery in COVID-19–free surgical pathways during the SARS-CoV-2 pandemic: an international, multicenter, comparative cohort study
Aneel Bhangu, 6 Oct 2020, In: Journal of Clinical Oncology . 14 p., JCO2001933.Research output: Contribution to journal › Article › peer-review
- Published
De-escalation after DE-ESCALATE and RTOG 1016: a head and neck cancer InterGroup framework for future de-escalation studies
Hisham Mehanna, 1 Aug 2020, In: Journal of Clinical Oncology . 38, 22, p. 2552-2557 7 p.Research output: Contribution to journal › Article › peer-review
- E-pub ahead of print
Overestimation of Late Distant Recurrences in High-Risk Patients With ER-Positive Breast Cancer: Validity and Accuracy of the CTS5 Risk Score in the TEAM and IDEAL Trials
Daniel Rea, 24 Jul 2020, In: Journal of Clinical Oncology . p. JCO1902427Research output: Contribution to journal › Article › peer-review
- Published
Less is not necessarily more: toward a rational selection of the conditioning regimen in acute myeloid leukemia
Sylvie Freeman, 20 Apr 2020, In: Journal of Clinical Oncology . 38, 12, p. 1249-1251 3 p.Research output: Contribution to journal › Editorial
- Published
ARISTOTLE: A phase III trial comparing concurrent capecitabine with capecitabine and irinotecan (Ir) chemoradiation as preoperative treatment for MRI-defined locally advanced rectal cancer (LARC).
Simon Bach, 2020, In: Journal of Clinical Oncology . p. 4101-410 9 p.Research output: Contribution to journal › Article › peer-review
- 2019
- Published
Ibrutinib plus venetoclax in relapsed/refractory chronic lymphocytic leukemia: the CLARITY study
Kristian Brock, Sam Munoz Vicente, Becky Boucher, 20 Oct 2019, In: Journal of Clinical Oncology . 37, 30, p. 2722-2729 8 p.Research output: Contribution to journal › Article › peer-review
- Published
Trans-aTTom: Breast Cancer Index for prediction of endocrine benefit and late distant recurrence (DR) in patients with HR+ breast cancer treated in the adjuvant tamoxifen—To offer more? (aTTom) trial.
Ikhlaaq Ahmed, Sarah Pirrie & Daniel Rea, 20 May 2019, In: Journal of Clinical Oncology. 37, 15_suppl, p. 505 1 p.Research output: Contribution to journal › Abstract › peer-review
- Published
Combination Lenalidomide and Azacitidine: A Novel Salvage Therapy in Patients Who Relapse After Allogeneic Stem-Cell Transplantation for Acute Myeloid Leukemia
Charles Craddock, Daniel Slade, Carmela De Santo, Rachel Hoare, Kristian Brock & Christina Yap, 1 Mar 2019, In: Journal of Clinical Oncology . 37, 7, p. 580-588 9 p., JCO1800889.Research output: Contribution to journal › Article › peer-review
- Published
High-dose chemotherapy compared with standard chemotherapy and lung radiation in ewing sarcoma with pulmonary metastases: Results of the european ewing tumour working initiative of national groups, 99 trial and ewing 2008
& 22 others, , 1 Jan 2019, In: Journal of Clinical Oncology. 37, 34, p. 3192-3202 11 p.Research output: Contribution to journal › Article › peer-review
- 2018
- E-pub ahead of print
High-dose chemotherapy and blood autologous stem-cell rescue compared with standard chemotherapy in localized high-risk Ewing sarcoma: results of Euro-E.W.I.N.G.99 and Ewing-2008
6 Sep 2018, In: Journal of Clinical Oncology . 16 p.Research output: Contribution to journal › Article › peer-review
- E-pub ahead of print
Hydroxycarbamide Plus Aspirin Versus Aspirin Alone in Patients With Essential Thrombocythemia Age 40 to 59 Years Without High-Risk Features
Keith Wheatley, 28 Aug 2018, In: Journal of Clinical Oncology .Research output: Contribution to journal › Article › peer-review
- E-pub ahead of print
Risk, risk factors and surveillance of subsequent malignant neoplasms in childhood cancer survivors: a review
Raoul Reulen, 6 Jun 2018, In: Journal of Clinical Oncology . 36, 9 p.Research output: Contribution to journal › Article › peer-review
- E-pub ahead of print
Development and validation of a combined metabolic and immune prognostic classifier for head and neck cancer
Jill Brooks, Lucinda Archer, Rachel Spruce, Nikos Batis, Jennifer Bryant, Andrew Beggs, Daniel Tennant, Gary Middleton, Jean-Baptiste Cazier, Benjamin Willcox, 1 Jun 2018, In: Journal of Clinical Oncology. 36, 15 Suppl, p. 6049-6049Research output: Contribution to journal › Abstract › peer-review
- Published
Measurable residual disease at induction redefines partial response in acute myeloid leukemia and stratifies outcomes in patients at standard risk without NPM1 mutations
Sylvie Freeman, Naeem Khan, 20 May 2018, In: Journal of Clinical Oncology . 36, 15, p. 1486-1497 12 p.Research output: Contribution to journal › Article › peer-review
- Published
Dasatinib in pediatric patients with chronic myeloid leukemia in chronic phase: results from a phase II trial
Pamela Kearns, 1 May 2018, In: Journal of Clinical Oncology . 36, 13, p. 1330-1338 9 p.Research output: Contribution to journal › Article › peer-review
- Published
Tumor PIK3CA genotype and prognosis in early-stage breast cancer: A pooled analysis of individual patient data
& 12 others, , 1 Apr 2018, In: Journal of Clinical Oncology. 36, 10, p. 981-990 10 p.Research output: Contribution to journal › Article › peer-review
- Published
Results of POUT: A phase III randomised trial of perioperative chemotherapy versus surveillance in upper tract urothelial cancer (UTUC)
9 Feb 2018, In: Journal of Clinical Oncology . 36, Suppl 6S, Abstract 407.Research output: Contribution to journal › Abstract › peer-review
- 2017
- Published
Improving outcomes in high-risk Myelodysplasia: Festina Lente
Charles Craddock, 26 May 2017, In: Journal of Clinical Oncology . p. JCO2017730812Research output: Contribution to journal › Editorial › peer-review
- E-pub ahead of print
Multicenter, Phase III, Randomized, Double-Blind, Placebo-Controlled Trial of Pravastatin Added to First-Line Standard Chemotherapy in Small-Cell Lung Cancer (LUNGSTAR)
Gary Middleton, 27 Feb 2017, In: Journal of Clinical Oncology .Research output: Contribution to journal › Article › peer-review
Impact of Viral Status on Survival in Patients Receiving Sorafenib for Advanced Hepatocellular Cancer: A Meta-Analysis of Randomized Phase III Trials
20 Feb 2017, In: Journal of Clinical Oncology . 35, 6, p. 622-628 7 p.Research output: Contribution to journal › Article › peer-review
- Published
Randomized prospective biomarker trial of ERCC1 for comparing platinum and nonplatinum therapy in advanced non-small-cell lung cancer: ERCC1 Trial (ET)
Gary Middleton, David Ferry & 3 others, , 1 Feb 2017, In: Journal of Clinical Oncology . 35, 4, p. 402-411 10 p.Research output: Contribution to journal › Article › peer-review
- 2016
- Published
Risk of Adverse Health and Social Outcomes Up to 50 Years After Wilms Tumor: The British Childhood Cancer Survivor Study
Raoul Reulen, Emma Lancashire & Michael Hawkins, 20 May 2016, In: Journal of Clinical Oncology . 34, 15, p. 1772-1779Research output: Contribution to journal › Article › peer-review
- 2015
- Published
Postoperative adjuvant lapatinib and concurrent chemoradiotherapy followed by maintenance lapatinib monotherapy in high-risk patients with resected squamous cell carcinoma of the head and neck: a phase III, randomized, double-blind, placebo-controlled study
Hisham Mehanna & 5 others, , 10 Dec 2015, In: Journal of Clinical Oncology . 33, 35, p. 4202-4209Research output: Contribution to journal › Article › peer-review
- Published
Prediction of Allogeneic Hematopoietic Stem-Cell Transplantation Mortality 100 Days After Transplantation Using a Machine Learning Algorithm: A European Group for Blood and Marrow Transplantation Acute Leukemia Working Party Retrospective Data Mining Study
Charles Craddock, 1 Oct 2015, In: Journal of Clinical Oncology . 33, 28, p. 3144-51 8 p.Research output: Contribution to journal › Article › peer-review
- Published
Collaborative Research in Childhood Cancer Survivorship: The Current Landscape
Michael Hawkins, 20 Sep 2015, In: Journal of Clinical Oncology . 33, 27, p. 3055-64 10 p.Research output: Contribution to journal › Article › peer-review
- Published
Predicting anthracycline benefit: TOP2A and CEP17 - Not only but also
Daniel Rea, 20 May 2015, In: Journal of Clinical Oncology. 33, 15, p. 1680-1687 8 p.Research output: Contribution to journal › Article › peer-review
- Published
Assessment of liver function in patients with hepatocellular carcinoma: a new evidence-based approach-the ALBI grade
Rich Fox, 20 Feb 2015, Journal of Clinical Oncology , 33, 6, p. 550 558 p.Research output: Contribution to specialist publication › Article
- 2014
- Published
Mutational Analysis of PI3K/AKT Signaling Pathway in Tamoxifen Exemestane Adjuvant Multinational Pathology Study
Daniel Rea, 20 Sep 2014, In: Journal of Clinical Oncology. 32, 27, p. 2951-2958Research output: Contribution to journal › Article › peer-review
- Published
Cyclophosphamide compared with ifosfamide in consolidation treatment of standard-risk Ewing sarcoma: results of the randomized noninferiority Euro-EWING99-R1 trial
Keith Wheatley, 10 Aug 2014, In: Journal of Clinical Oncology . 32, 23, p. 2440-8 9 p.Research output: Contribution to journal › Article › peer-review
- Published
Predictive importance of ulceration on the efficacy of adjuvant interferon-a (IFN): An individual patient data (IPD) meta-analysis of 15 randomized trials in more than 7,500 melanoma patients (pts).
Natalie Rowland & Keith Wheatley, 20 May 2014, In: Journal of Clinical Oncology . 32, 15_suppl, 9067.Research output: Contribution to journal › Article › peer-review
- Published
Genetic markers of toxicity from capecitabine and other fluorouracil-based regimens: investigation in the QUASAR2 study, systematic review, and meta-analysis
Claire Palles & 24 others, , 1 Apr 2014, In: Journal of Clinical Oncology . 32, 10, p. 1031-1039 9 p.Research output: Contribution to journal › Article › peer-review
- 2013
- Published
Reply to K.I. Pritchard
Daniel Rea, 10 Dec 2013, In: Journal of Clinical Oncology. 31, 35, p. 4477-4479 3 p.Research output: Contribution to journal › Article › peer-review
- Published
Prognostic Relevance of Treatment Response Measured by Flow Cytometric Residual Disease Detection in Older Patients With Acute Myeloid Leukemia
Sylvie Freeman, Robert Hills, Nov 2013, In: Journal of Clinical Oncology.Research output: Contribution to journal › Article › peer-review
- Published
Optimization of chemotherapy for younger patients with acute myeloid leukemia: results of the medical research council AML15 trial
Robert Hills, Keith Wheatley, 20 Sep 2013, In: Journal of Clinical Oncology . 31, 27, p. 3360-8 9 p.Research output: Contribution to journal › Article › peer-review
- Published
Is uterine serous carcinoma a part of hereditary breast cancer syndrome
Sudha Sundar, 10 Sep 2013, In: Journal of Clinical Oncology . 31, 26Research output: Contribution to journal › Article › peer-review
- Published
Minimal Residual Disease Assessed by Multiparameter Flow Cytometry in Multiple Myeloma: Impact on Outcome in the Medical Research Council Myeloma IX Study
Mark Drayson, 10 Jul 2013, In: Journal of Clinical Oncology . 31, 20, p. 2540-7 8 p.Research output: Contribution to journal › Article › peer-review
- Published
Dasatinib in children and adolescents with relapsed or refractory leukemia: results of the CA180-018 phase I dose-escalation study of the Innovative Therapies for Children with Cancer Consortium.
Pamela Kearns, 1 Jul 2013, In: Journal of Clinical Oncology . 31, 19, p. 2460-2468 9 p.Research output: Contribution to journal › Article › peer-review
- Published
Clinical outcomes in patients with castrate-refractory prostate cancer (CRPC) metastatic to bone randomized in the factorial TRAPEZE trial to docetaxel (D) with strontium-89 (Sr89), zoledronic acid (ZA), neither, or both (ISRCTN 12808747)
Lucinda Billingham, Stuart Collins, Emilio Porfiri, 20 Jun 2013, In: Journal of Clinical Oncology . 31, 18_suppl, p. LBA5000Research output: Contribution to journal › Article › peer-review
- Published
Specific adverse events predict survival benefit in patients treated with tamoxifen or aromatase inhibitors: An international tamoxifen exemestane adjuvant multinational trial analysis
Daniel Rea, 20 Jun 2013, In: Journal of Clinical Oncology. 31, 18, p. 2257-2264 8 p.Research output: Contribution to journal › Article › peer-review
- Published
Use of serum markers in prediction of survival in the trapeze factorial trial evaluating docetaxel with zoledronic acid, strontium-89, or both in castrate-refractory prostate cancer (CRPC) metastatic to bone
Kaisheng Wen, Sarah Pirrie & Nicholas James, 3 Jun 2013, In: Journal of Clinical Oncology . 31 (supplement), suppl; abstr 5057.Research output: Contribution to journal › Abstract › peer-review
- Published
Impact of gender on efficacy and acute toxicity in standard risk localized (SR) Ewing sarcomas (ES) in the Euro-Ewing99-R1 trial
Keith Wheatley, 20 May 2013, In: Journal of Clinical Oncology . 31, suppl 15, abstr 10031.Research output: Contribution to journal › Article › peer-review
- Published
Curability of patients with acute myeloid leukemia who did not undergo transplantation in first remission
Robert Hills, Keith Wheatley, 1 Apr 2013, In: Journal of Clinical Oncology . 31, 10, p. 1293-301 9 p.Research output: Contribution to journal › Article › peer-review
- Published
Muscle invasive bladder cancer in the elderly: Treatment and prognosis in a prospective cohort study
Tom Wright, Adam Devall, Sarah Pirrie, Lucinda Billingham, KK Cheng, Rik Bryan, 20 Feb 2013, In: Journal of Clinical Oncology . 31, 6_suppl, p. 275Research output: Contribution to journal › Article › peer-review
- Published
Results of a Randomized Trial of Chlorambucil Versus Fludarabine for Patients With Untreated Waldenstrom Macroglobulinemia, Marginal Zone Lymphoma, or Lymphoplasmacytic Lymphoma
Dickens Pratt & 1 others, , 20 Jan 2013, In: Journal of Clinical Oncology. 31, 3, p. 301-307Research output: Contribution to journal › Article › peer-review
- 2012
- Published
Mammostrat as an immunohistochemical multigene assay for prediction of early relapse risk in the tamoxifen versus exemestane adjuvant multicenter trial pathology study
Daniel Rea, 20 Dec 2012, In: Journal of Clinical Oncology . 30, 36, p. 4477-84 8 p.Research output: Contribution to journal › Article › peer-review
- Published
Addition of gemtuzumab ozogamicin to induction chemotherapy improves survival in older patients with acute myeloid leukemia
Robert Hills, Sylvie Freeman, Charles Craddock, Keith Wheatley, 2012, In: Journal of Clinical Oncology . 30, 32, p. 3924-31 8 p.Research output: Contribution to journal › Article › peer-review
- Published
Biallelic ATM Inactivation Significantly Reduces Survival in Patients Treated on the United Kingdom Leukemia Research Fund Chronic Lymphocytic Leukemia 4 Trial
Anna Skowronska, Ceri Oldreive, Malcolm Taylor, Paul Moss & Tatjana Stankovic, 2012, In: Journal of Clinical Oncology . 30, 36, p. 4524-4532 9 p.Research output: Contribution to journal › Article › peer-review
- 2011
- Published
Validation Study of a Quantitative Multigene Reverse Transcriptase-Polymerase Chain Reaction Assay for Assessment of Recurrence Risk in Patients With Stage II Colon Cancer.
Richard Gray, Kelly Handley, Laura Magill, 7 Nov 2011, In: Journal of Clinical Oncology.Research output: Contribution to journal › Article